Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dual therapy vs furazolidone-based quadruple therapy for H. pylori rescue treatment
NCT05176821Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of amoxicillin and esomeprazole in Helicobacter pylori infection, sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Helicobacter pylori eradication rate at 42 days. Status: unknown.
02
Drugs
amoxicillinesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05176821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05176821.